Medical physics: Latest News, Top Stories & Analysis

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced this week the issuance of United States Patent # 10,953,113. The patent claims a quick (5 min), easy and quantitative …

Products and Services / Research

Molecular Targeting Technologies: New Radiotherapeutic Is Effective and Less Toxic for Neuroendocrine Tumor Patients

March 27, 2021March 25, 2021 - by MyChesCo

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced an article entitled “Peptide Receptor Radionuclide Therapy (PRRT) of Late-Stage Neuroendocrine Tumor (NETs) Patients with Multiple Cycles of Lu-DOTA-EB-TATE” just …